van Vugt LK - Search Results

1

[Acute kidney injury, an avoidable problem].

van Vugt LK, Wagenaar E, van Etten RW. van Vugt LK, et al. Ned Tijdschr Geneeskd. 2021 Apr 8;165:D5528. Ned Tijdschr Geneeskd. 2021. PMID: 33914430 Dutch.

2

Multicenter, Real-World Clinical Evaluation of Alemtuzumab and Anti-Thymocyte Globulin for Severe Acute T Cell-Mediated Kidney Transplant Rejection.

van Vugt LK, Tegzess E, van der Zwan M, Clahsen-van Groningen MC, de Winter BCM, Vart P, Reinders MEJ, Sanders JSF, Berger SP, Hesselink DA. van Vugt LK, et al. Clin Transplant. 2024 Dec;38(12):e70046. doi: 10.1111/ctr.70046. Clin Transplant. 2024. PMID: 39636744 Free PMC article.

3

Investigational drugs for the treatment of kidney transplant rejection.

van Vugt LK, Schagen MR, de Weerd A, Reinders ME, de Winter BC, Hesselink DA. van Vugt LK, et al. Expert Opin Investig Drugs. 2022 Oct;31(10):1087-1100. doi: 10.1080/13543784.2022.2130751. Epub 2022 Oct 7. Expert Opin Investig Drugs. 2022. PMID: 36175360 Free article. Review.

4

Personalized anti-rejection therapy with alemtuzumab for kidney transplant recipients.

Hesselink DA, Hullegie-Peelen DM, van Vugt LK. Hesselink DA, et al. Among authors: van vugt lk. Pharmacogenomics. 2022 Jul;23(10):567-570. doi: 10.2217/pgs-2022-0071. Epub 2022 Jun 28. Pharmacogenomics. 2022. PMID: 35763447 No abstract available.

5

Recurrent treatment of refractory acute cellular rejection with alemtuzumab after lung transplantation.

van Haren E, van Vugt LK, Wijbenga N, van der Sijs H, Hellemons ME. van Haren E, et al. Among authors: van vugt lk. J Heart Lung Transplant. 2024 Nov;43(11):1864-1868. doi: 10.1016/j.healun.2024.07.004. Epub 2024 Jul 14. J Heart Lung Transplant. 2024. PMID: 39009290 Free article.

6

Challenges for the improvement of valganciclovir prophylaxis in solid organ transplantation and the possible role of therapeutic drug monitoring in adults.

van Vugt LK, Hesselink DA, de Winter BCM. van Vugt LK, et al. Br J Clin Pharmacol. 2024 Jun 18. doi: 10.1111/bcp.16138. Online ahead of print. Br J Clin Pharmacol. 2024. PMID: 38889884

7

A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection.

van Vugt LK, van der Zwan M, Clahsen-van Groningen MC, van Agteren M, Hullegie-Peelen DM, De Winter BCM, Reinders MEJ, Miranda Afonso P, Hesselink DA. van Vugt LK, et al. Transpl Int. 2023 Nov 7;36:11834. doi: 10.3389/ti.2023.11834. eCollection 2023. Transpl Int. 2023. PMID: 38020744 Free PMC article.

8

Meta-analysis of postoperative pain using non-sutured or sutured single-layer open mesh repair for inguinal hernia.

van Steensel S, van Vugt LK, Al Omar AK, Mommers EHH, Breukink SO, Stassen LPS, Winkens B, Bouvy ND. van Steensel S, et al. Among authors: van vugt lk. BJS Open. 2019 Feb 27;3(3):260-273. doi: 10.1002/bjs5.50139. eCollection 2019 Jun. BJS Open. 2019. PMID: 31183441 Free PMC article.

9

Shape-Dependent Multiexciton Emission and Whispering Gallery Modes in Supraparticles of CdSe/Multishell Quantum Dots.

Vanmaekelbergh D, van Vugt LK, Bakker HE, Rabouw FT, de Nijs B, van Dijk-Moes RJ, van Huis MA, Baesjou PJ, van Blaaderen A. Vanmaekelbergh D, et al. Among authors: van vugt lk. ACS Nano. 2015 Apr 28;9(4):3942-50. doi: 10.1021/nn507310f. Epub 2015 Apr 9. ACS Nano. 2015. PMID: 25844664

10

All-optical active switching in individual semiconductor nanowires.

Piccione B, Cho CH, van Vugt LK, Agarwal R. Piccione B, et al. Among authors: van vugt lk. Nat Nanotechnol. 2012 Oct;7(10):640-5. doi: 10.1038/nnano.2012.144. Epub 2012 Sep 2. Nat Nanotechnol. 2012. PMID: 22941404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters